Drug
Aprotinin
Aprotinin is a pharmaceutical drug with 5 clinical trials. Historical success rate of 75.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
75.0%
Based on 3 completed trials
Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(20%)
Phase Distribution
Ph phase_1
2
40%
Ph not_applicable
2
40%
Phase Distribution
2
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(3)
Terminated(1)
Other(1)
Detailed Status
Completed3
Terminated1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
75.0%
Most Advanced
Phase 1
Trials by Phase
Phase 12 (50.0%)
N/A2 (50.0%)
Trials by Status
completed360%
terminated120%
unknown120%
Recent Activity
0 active trials
Showing 5 of 5
unknownnot_applicable
An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19
NCT04527133
completed
Effects of Aprotinin During Cardiac Surgery/Long Term Death Rates
NCT00617955
completednot_applicable
Investigation of Leukocyte Trafficking Into Skin Blisters During Cardiopulmonary Bypass
NCT00131040
completedphase_1
Can Aprotinin Reduce Pancreatitis After Scoliosis Surgery
NCT00357851
terminatedphase_1
Phase I Study of Aprotinin in Advanced Breast Cancer
NCT00354900
Clinical Trials (5)
Showing 5 of 5 trials
NCT04527133Not Applicable
An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19
NCT00617955
Effects of Aprotinin During Cardiac Surgery/Long Term Death Rates
NCT00131040Not Applicable
Investigation of Leukocyte Trafficking Into Skin Blisters During Cardiopulmonary Bypass
NCT00357851Phase 1
Can Aprotinin Reduce Pancreatitis After Scoliosis Surgery
NCT00354900Phase 1
Phase I Study of Aprotinin in Advanced Breast Cancer
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5